TY - JOUR
TI - Prevalence of non-coronary heart disease in patients with familial hyperc-holesterolemia: An analysis from the HELLAS-FH
AU - Anagnostis, P.
AU - Rizos, C.V.
AU - Skoumas, I.
AU - Rallidis, L.
AU - Tziomalos, K.
AU - Skalidis, E.
AU - Kotsis, V.
AU - Doumas, M.
AU - Kolovou, G.
AU - Sfikas, G.
AU - Bilianou, E.
AU - Koutagiar, I.
AU - Agapakis, D.
AU - Zacharis, E.
AU - Antza, C.
AU - Koumaras, C.
AU - Boutari, C.
AU - Liamis, G.
AU - Liberopoulos, E.N.
JO - Current Pharmaceutical Design
PY - 2021
VL - 27
TODO - 21
SP - 2537-2544
PB - Bentham Science Publishers
SN - 1381-6128
TODO - 10.2174/1381612827666210216151645
TODO - adult;  aged;  arterial wall thickness;  complication;  coronary artery disease;  cross-sectional study;  familial hypercholesterolemia;  genetics;  human;  male;  middle aged;  prevalence;  risk factor, Adult;  Aged;  Carotid Intima-Media Thickness;  Coronary Disease;  Cross-Sectional Studies;  Humans;  Hyperlipoproteinemia Type II;  Male;  Middle Aged;  Prevalence;  Risk Factors
TODO - Aims: Despite the established link between familial hypercholesterolemia (FH) and increased risk of coronary heart disease (CHD), its association with other common atherosclerotic and metabolic diseases has not been extensively studied. The aim of this study was to report the prevalence of peripheral arterial disease (PAD) [i.e., common carotid artery disease (CCAD) and lower extremity arterial disease (LEAD)], aortic valve stenosis, chronic kidney disease (CKD) and non-alcoholic fatty liver disease (NAFLD) in patients with FH. Materials & Methods: This was a cross-sectional study retrieving data from the Hellenic Familial Hypercholes-terolemia Registry (HELLAS-FH). Results: A total of 1,633 adult patients (850 males) with heterozygous FH (HeFH) were included (mean age 51.3±14.6 years at registration and 44.3±15.9 years at diagnosis). Any common carotid artery stenosis (CCAS) was diagnosed in 124 out of 569 patients with available related data (21.8%), while the prevalence of CCAD (defined as a CCAS ≥50%) was 4.2%. The median (interquartile range-IQR) CCAS was 30% (20-40), whereas the median (IQR) carotid intima-media thickness (CIMT) was 0.7 (0.1-1.4) mm. LEAD was reported in 44 patients (prevalence 2.7%). The prevalence of aortic valve stenosis and CKD was 2.0% and 6.4%, respec-tively. NAFLD was present in 24% of study participants. Conclusion: HeFH is associated with a relatively high prevalence of any CCAS and CCAD. The prevalence of LEAD, CKD and aortic valve stenosis was relatively low, whereas the prevalence of NAFLD was similar to that of the general population. © 2021 Bentham Science Publishers.
ER -